Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luiza R. Cruz
Observed names:
Luiza R. Cruz,
Luiza Cruz,
Luiza R Cruz,
Luiza dos Reis Cruz,
Luíza dos Reis Cruz
Institutions:
Drugs for Neglected Diseases Initiative,
Universidade Estadual de Campinas (UNICAMP)
Observed institutions:
Drugs for Neglected Diseases Initiative,
Universidade Estadual de Campinas (UNICAMP),
Medicines for Malaria Venture,
The University of Texas at Austin
ORCID:
0000-0001-6103-9345
Observed ORCID:
0000-0001-6103-9345
OpenAlex ID:
A5032470700
Spirocyclic compounds as innovative tools in drug discovery for medicinal chemists
2025
·
Marina T. Varela
, Gleiston G. Dias
, et al.
·
European Journal of Medicinal Chemistry
·
79
The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice
2020
·
Sema G. Quadir
, Sean M. Tanino
, et al.
·
Neuropharmacology
·
33
Malaria in South America: a drug discovery perspective
2013
·
Luiza R Cruz
, Thomas Spangenberg
, et al.
·
Malaria Journal
·
25
PDF
Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021
2021
·
Ramon G. de Oliveira
, Luiza R. Cruz
, et al.
·
Frontiers in Chemistry
·
21
PDF
Discovery and Early Optimization of 1 H -Indole-2-carboxamides with Anti- Trypanosoma cruzi Activity
2025
·
Ramon G. de Oliveira
, Luiza R. Cruz
, et al.
·
Journal of Medicinal Chemistry
·
4
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure–Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments
2025
·
Zigli Abdulai
, Natasha Agbo
, et al.
·
ACS Infectious Diseases
·
3
PDF
Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis , the main causative agent of mycetoma
2025
·
Hung Phat Duong
, Dmitrij Melechov
, et al.
·
RSC Medicinal Chemistry
·
3
PDF
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives
2024
·
Brian W. Slafer
, Marco A. Dessoy
, et al.
·
ACS Omega
·
2
PDF
Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay
2026
·
Camila Colombari Mantovani
, Flavia R. Novais Freitas
, et al.
·
International Journal for Parasitology Drugs and Drug Resistance
PDF
Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection
2026
·
Júlia Kelly Campos
, Scarleth Silva Costa
, et al.
·
Parasitology International
Call for Papers: Bridging Gaps in Global Health with Medicinal Chemistry
2025
·
Luiza Cruz
, Lori Ferrins
, et al.
·
Journal of Medicinal Chemistry
Author response for "Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of eumycetoma"
2025
·
Hung Phat Duong
, Dmitrij Melechov
, et al.
Journal of Medicinal Chemistry Collection: Drug Discovery in South America
2024
·
Tiago Rodrigues
, Luiza Cruz
·
Journal of Medicinal Chemistry
PDF
Spiraling Forward: Spirocyclic Compounds as Innovative Tools in Drug Discovery for Medicinal Chemists
2024
·
Marina T. Varela
, Gleiston G. Dias
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
14
Citation count:
170
H-index:
4
I10-index:
4
Year
Topic
Type
